Showing all 12 results

Show sidebar
Show 9 12 18 24
Compare

Cabenuva (cabotegravir + rilpivirine)

£4,744.12 – £7,116.17
Cabenuva (cabotegravir + rilpivirine) is an injectable, long-acting, complete regimen for HIV-1 infected adults that is administered once a month.
Add to wishlist
Select options
Quick view
Compare

Descovy (emtricitabine/tenofovir alafenamide)

£564.54 – £1,690.00
Descovy (emtricitabine/tenofovir alafenamide) is a medication used for the treatment of human immunodeficiency virus type 1 (HIV-1).
Add to wishlist
Select options
Quick view
Compare

Hydroxychloroquine/Teva (hydroxychloroquine sulfate)

Our mission is to safeguard the health of our patients by supporting them to access safe and life-improving medicines.

For that reason everyone.org will not provide access to Hydroxycholoroquine to treat patients with COVID-19 following the recent WHO decision to suspend its Solidarity Trial of Hydroxycholoroquine until the safety data is reviewed by its Data Safety Monitoring Board.

Please only submit an enquiry for this medicine if you need it for its prescribed and approved purpose.

Hydroxychloroquine Teva (hydroxychloroquine sulfate) is a generic drug of Plaquenil (hydroxychloroquine sulfate) and is a medicine for treating uncomplicated malaria, chronic discoid lupus erythematosus, systemic lupus erythematosus, and acute and chronic rheumatoid arthritis in adults.

The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.

Add to wishlist
Price available on request
Quick view
Compare

Lagevrio (molnupiravir)

Lagevrio (molnupiravir) is a prescription medicine used to treat mild-to-moderate COVID-19 (caused by SARS-CoV-2) in adults who are at risk for developing severe illness. This medicine has been given ‘conditional approval’. This means that there is more evidence to come about its efficacy.
Add to wishlist
Price available on request
Quick view
Compare

Olumiant (baricitinib)

£1,306.70 – £4,455.46
Olumiant (baricitinib) is a medication used for the treatment of rheumatoid arthritis and for the treatment of moderate to severe atopic dermatitis. On November 19, 2020 the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Olumiant (baricitinib), in combination with Veklury (remdesivir), to treat COVID-19 patients.
Add to wishlist
Select options
Quick view
Compare

Pifeltro (doravirine)

£683.80 – £1,981.69
Pifeltro (doravirine) is prescription medicine that is used together with other antiviral medicines. to treat HIV-1 infected adults.
Add to wishlist
Select options
Quick view
Compare

RoActemra (tocilizumab)

£2,893.97
RoActemra (tocilizumab) is a medicine used for the treatment of severe COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis or juvenile idiopathic polyarthritis. It is approved by the Food and Drugs Administration (FDA), USA, under the brand-name Actemra.
Add to wishlist
Add to cart
Quick view
Compare

Rukobia (fostemsavir)

£3,222.60
Rukobia (fostemsavir) is a first-in-class attachment inhibitor used for the treatment of HIV-1.
Add to wishlist
Add to cart
Quick view
Compare

Truvada (emtricitabine / tenofovir disoproxil)

£943.80
Truvada (emtricitabine / tenofovir disoproxil) is a medication used in combination with at least one other antiviral medicine for the treatment of human immunodeficiency virus type 1 (HIV-1) infection or prevention (PrEP).
Add to wishlist
Add to cart
Quick view
Compare

Veklury (remdesivir)

Veklury (remdesivir) is an antiviral medication indicated for the treatment of COVID-19 in adults and adolescents from 12 years of age with pneumonia who require supplemental oxygen. Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2 infection).
Add to wishlist
Price available on request
Quick view
Compare

Vocabria (cabotegravir)

£789.10
Vocabria (cabotegravir) is prescription medicine that is used together with rilpivirine to treat HIV-1 infected adults.
Add to wishlist
Add to cart
Quick view
Compare

Xofluza (baloxavir marboxil)

Xofluza (baloxavir marboxil) is indicated for the treatment acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hours. This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.
Add to wishlist
Price available on request
Quick view